TY - JOUR
T1 - Screening tests during prenatal care
T2 - Does practice follow the evidence?
AU - Siddique, Juned
AU - Lantos, John D.
AU - VanderWeele, Tyler J.
AU - Lauderdale, Diane S.
N1 - Funding Information:
This study was supported by an Investigator Award in Health Policy Research from the Robert Wood Johnson Foundation and by the Chicago Center for Health Promotion Economics
PY - 2012/1
Y1 - 2012/1
N2 - To examine whether the frequency of four screening tests during prenatal care conforms to evidence of effectiveness. We estimated rates of urine culture, anemia screening, oral glucose tolerance test (OGTT), and urinalysis during prenatal care. To do this, we used national probability samples of office visits to physicians (National Ambulatory Medical Care Survey) and to hospital outpatient departments (National Hospital Ambulatory Medical Care Survey) from 2001 to 2006. We compare observed rates to recommendations from the U.S. Preventive Services Task Force (USPSTF). On average, women received a urine culture in less than half of pregnancies. Women received just over one anemia screening on average per pregnancy. From 2001-2003, women received an average of 5.6 urinalyses per pregnancy; the average dropped to 4.3 urinalyses per pregnancy in 2004-2006. On average, women received just under one OGTT per pregnancy. Minorities and older women tend to get more anemia screenings, urine cultures, and OGTTs than white women and younger women. Compared to USPSTF recommendations, too few women are receiving a urine culture during prenatal care. In contrast, women receive far too many urinalyses, but the rate appears to be falling. Anemia screening conforms closely to recommendations. The USPSTF does not recommend for or against universal diabetes screening using OGTT. Women appear to receive OGTT routinely.
AB - To examine whether the frequency of four screening tests during prenatal care conforms to evidence of effectiveness. We estimated rates of urine culture, anemia screening, oral glucose tolerance test (OGTT), and urinalysis during prenatal care. To do this, we used national probability samples of office visits to physicians (National Ambulatory Medical Care Survey) and to hospital outpatient departments (National Hospital Ambulatory Medical Care Survey) from 2001 to 2006. We compare observed rates to recommendations from the U.S. Preventive Services Task Force (USPSTF). On average, women received a urine culture in less than half of pregnancies. Women received just over one anemia screening on average per pregnancy. From 2001-2003, women received an average of 5.6 urinalyses per pregnancy; the average dropped to 4.3 urinalyses per pregnancy in 2004-2006. On average, women received just under one OGTT per pregnancy. Minorities and older women tend to get more anemia screenings, urine cultures, and OGTTs than white women and younger women. Compared to USPSTF recommendations, too few women are receiving a urine culture during prenatal care. In contrast, women receive far too many urinalyses, but the rate appears to be falling. Anemia screening conforms closely to recommendations. The USPSTF does not recommend for or against universal diabetes screening using OGTT. Women appear to receive OGTT routinely.
KW - Evidence-based care
KW - Pregnancy
KW - Prenatal
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84860885072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860885072&partnerID=8YFLogxK
U2 - 10.1007/s10995-010-0723-3
DO - 10.1007/s10995-010-0723-3
M3 - Article
C2 - 21113814
AN - SCOPUS:84860885072
VL - 16
SP - 51
EP - 59
JO - Maternal and Child Health Journal
JF - Maternal and Child Health Journal
SN - 1092-7875
IS - 1
ER -